Recently, the "Paracurve® Radial Access Guiding Catheter," independently developed by AccuMedical (Beijing) Co., Ltd., was approved for registration by the National Medical Products Administration (NMPA). The product has obtained a Class III medical device registration certificate with the registration number: NMPA 20243030848.
This product is designed for introducing interventional devices into neurovascular, peripheral, and coronary arteries via the radial artery. It includes a guiding catheter and a selective catheter.
AccuMedical is a commercialized innovative medical device company specializing in the field of neurointervention. Founded in 2017, AccuMedical is headquartered in Beijing with dual R&D centers in China and the United States. AccuMedical has developed comprehensive businesses including R&D, production, and marketing of neurointerventional devices for the treatment of hemorrhagic and ischemic strokes. Our mission is to offer a whole set of innovative solutions to a global population of cerebrovascular disease patients and physicians. As of March 2024, the company has filed 111 patent applications, with 65 patents granted.